MAXHEALTHBSEMax Healthcare Institute LtdHighNeutral
Announced Thu, 21 May · 16:48 IST

Shifting of Registered Office from State of Maharashtra to State of Haryana

Pat Growth 25pctExceptional ItemEbitda Margin ExpansionResults View source PDF

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-8.5%1-day move
₹1093.15
prior close
₹1068.25
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.7-3.9-4.7-4.6-8.5-9.2-9.0-11.7-13.7-11.7-5.8-0.0-1.1
Up moveDown movePending
AI summary

Max Healthcare reported strong FY2026 consolidated results with revenue from operations growing 19.1% to ₹8,37,345 lakhs from ₹7,02,846 lakhs in FY2025. Profit after tax surged 34.1% to ₹1,44,241 lakhs from ₹1,07,588 lakhs, exceeding the 25% growth threshold. The Board recommended a final dividend of ₹2 per share (20% face value). Key corporate actions include: shifting registered office from Mumbai (Maharashtra) to Gurugram (Haryana), construction of a new ~712-bed Max Super Specialty Hospital in Lucknow, and re-classification of Radiant Life Care Hospital Foundation from Promoter Group to Public category. Exceptional items of ₹4,824 lakhs were recorded (₹3,390 lakhs for new labour codes impact and ₹1,434 lakhs for stamp duty on merger). Auditors S.R. Batliboi & Co. LLP issued an unmodified (clean) opinion on both standalone and consolidated financial results. The company also acquired a 58.28% stake in Kalinga Hospitals Limited in Bhubaneswar for ₹29,797 lakhs during the period.

Likely market impact

The stock demonstrates robust financial performance with PAT growth of 34% and clean audit opinion. The office relocation to Haryana aligns with the company's operational base, while the Lucknow hospital expansion and Kalinga acquisition signal continued geographic growth. The dividend and strong cash generation (₹1,63,332 lakhs operating cash flow) are positive signals for shareholders.